Insider Transactions in Q4 2023 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.34%
|
-
|
|
Dec 27
2023
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,362
-0.25%
|
-
|
|
Dec 27
2023
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,333
+0.63%
|
-
|
|
Dec 27
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+1.7%
|
-
|
|
Dec 27
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,410
-5.76%
|
-
|
|
Dec 27
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+12.77%
|
-
|
|
Dec 27
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,541
-7.48%
|
-
|
|
Dec 27
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+15.97%
|
-
|
|
Dec 27
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.63%
|
-
|
|
Dec 27
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,839
-17.24%
|
-
|
|
Dec 27
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+28.02%
|
-
|
|
Dec 27
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.4%
|
-
|
|
Dec 27
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+50.0%
|
-
|
|
Dec 27
2023
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,409
-13.92%
|
-
|
|
Dec 27
2023
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,666
+27.81%
|
-
|
|
Dec 27
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.21%
|
-
|
|
Dec 27
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-1.81%
|
-
|
|
Dec 27
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,666
+4.4%
|
-
|
|
Dec 15
2023
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
14,000
-100.0%
|
$196,000
$14.4 P/Share
|
|
Dec 15
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$50,000
$5.78 P/Share
|
|
Dec 12
2023
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
50,000
-13.04%
|
$650,000
$13.32 P/Share
|
|
Dec 12
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.53%
|
$50,000
$1.13 P/Share
|
|
Dec 11
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+15.83%
|
$150,000
$1.13 P/Share
|
|
Dec 11
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
60,000
-32.19%
|
$780,000
$13.77 P/Share
|
|
Dec 11
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+35.18%
|
$60,000
$1.13 P/Share
|
|
Dec 08
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
40,000
-25.22%
|
$560,000
$14.28 P/Share
|
|
Dec 08
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+30.64%
|
$40,000
$1.13 P/Share
|
|
Dec 07
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+22.39%
|
$60,000
$1.13 P/Share
|
|
Dec 06
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
50,000
-56.58%
|
$700,000
$14.02 P/Share
|
|
Dec 06
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.14%
|
$50,000
$1.13 P/Share
|
|
Dec 05
2023
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
40,000
-5.82%
|
$560,000
$14.24 P/Share
|